LifeStance Health Group (NASDAQ:LFST) Receives "Outperform" Rating from William Blair

William Blair reissued their outperform rating on shares of LifeStance Health Group (NASDAQ:LFST - Free Report) in a report issued on Friday morning,RTT News reports. William Blair also issued estimates for LifeStance Health Group's Q1 2025 earnings at ($0.03) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

Other analysts have also recently issued research reports about the company. Barclays increased their target price on LifeStance Health Group from $6.00 to $7.00 and gave the stock an "underweight" rating in a research report on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 price target on the stock in a research note on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $8.70.

LifeStance Health Group Stock Performance

LFST traded up $0.11 during trading on Friday, hitting $8.02. The company's stock had a trading volume of 2,832,852 shares, compared to its average volume of 1,298,169. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The business's 50 day simple moving average is $7.81 and its 200-day simple moving average is $7.26. The firm has a market cap of $3.07 billion, a PE ratio of -30.85 and a beta of 1.28. LifeStance Health Group has a one year low of $4.64 and a one year high of $8.61.

Remove Ads

Institutional Trading of LifeStance Health Group

Several institutional investors and hedge funds have recently made changes to their positions in LFST. Principal Financial Group Inc. boosted its position in LifeStance Health Group by 6.1% in the 3rd quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company's stock valued at $28,817,000 after buying an additional 235,316 shares during the period. Jennison Associates LLC raised its holdings in shares of LifeStance Health Group by 9.5% in the third quarter. Jennison Associates LLC now owns 2,136,942 shares of the company's stock valued at $14,959,000 after acquiring an additional 184,896 shares in the last quarter. Intech Investment Management LLC bought a new stake in shares of LifeStance Health Group in the 3rd quarter valued at about $311,000. Landscape Capital Management L.L.C. lifted its position in shares of LifeStance Health Group by 43.7% in the 3rd quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company's stock worth $2,576,000 after purchasing an additional 111,894 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company's stock worth $7,731,000 after buying an additional 297,723 shares during the period. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.